Asia could not buck the global trend of venture capital pullback in 2022, as total funding for the year dropped 39% compared to the record-setting...
Seed funding
For multiple years, the most active startup investors kept upping their games. They did more deals, backed larger rounds, and kept pushing up...
North American startup investment fell sharply in the fourth quarter, closing out 2022 with funding far below the prior year’s record-setting levels.
Venture and growth investors in private companies scaled back their investment pace significantly in the latter half of 2022, signaling a slower...
We here at Crunchbase love to talk about billions — billions in valuations, billions in revenue and billions in fundraising, even in a volatile year...
The sharp downturn in startup funding between 2021 and 2022 extends to venture-backed companies working on cancer therapies and diagnostics.
Global venture funding reached $22 billion in November 2022, down 69% from $70 billion in November 2021.
Few of the record 143 biotech startups that made their public debut last year had a product to sell. We unpack the odd nature of biotech IPOs.
The big global venture capital pullback we all expected is truly here. Venture funding for the third quarter of 2022 fell by 33% quarter over quarter.
Despite the volatility, fear and risk that is coming our way, those very things represent opportunity to keen investors. This cycle has repeated...
What’s the minimum needed to secure pre-seed venture funding? MGV's Marc Schröder shares his thoughts on exactly what pre/seed-stage VCs consider the...
67.1K Followers